Results 111 to 120 of about 14,033 (212)

Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aim The serologic prevalence of the Weak D phenotype varies across populations and may be influenced by laboratory methodology. However, nationwide data from Iran remain limited. This study aimed to determine the nationwide serologic prevalence of the Weak D phenotype among Iranian blood donors and to compare detection rates ...
Younes Sadeghi‐Bojd, Narges Sadat Razavi Alhosayni, Fatemeh Mirzaeyan, Fatemeh Mohammadali, Arezoo Oodi   +4 more
wiley   +1 more source

Use of an anti-D-alloimmunization kinetics model to correct the interval censored D-alloimmunization rate following red blood cell transfusions [PDF]

Introduction: The rate of D-alloimmunization amongst RhD-negative recipients of RhD-positive red blood cell (RBC) transfusions is not certain. Recipients with a short duration between the index RhD-positive transfusion and the last antibody detection ...
Selleng, Kathleen, Jochumsen, Emil Ainsworth, Sprogøe, Ulrik, Yazer, Mark H., Raval, Jay S., Bub, Carolina Bonet, Kutner, Jose M.   +6 more
core   +1 more source

Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease

European Journal of Haematology, Volume 117, Issue 4, Page 1052-1060, October 2026.
ABSTRACT Background Sickle cell disease (SCD) is a chronic and life‐limiting hemoglobin and systemic vascular disease. While over 1000 people have undergone hematopoietic cell transplantation (HCT) over the last 40 years, long‐term disease‐specific and health‐related quality of life data are lacking.
Gregory M. T. Guilcher, Allistair Abraham, Staci D. Arnold, Christine Camacho‐Bydume, Jenny Duong, Scott Gillespie, Ann Haight, Monica L. Hulbert, Naresh Kumar, Katie Liu, Cherry Mammen, Aleksandra Mineyko, Abra Morgan, Alexander Ngwube, Robert S. Nickel, Araby Roberts, Fiona Schulte, Stephen Sands, Akshay Sharma, John T. Horan, Elizabeth O. Stenger   +20 more
wiley   +1 more source

Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions

Transfusion, 2019
Patients with sickle cell disease (SCD) often require red blood cell (RBC) transfusions but alloimmunization remains a significant complication. Alloantibodies can lead to delayed hemolytic transfusion reactions (DHTRs) days to weeks after a RBC ...
Sarita L Coleman, C. Westhoff, David F. Friedman, Stella T. Chou   +3 more
semanticscholar   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Nabiha H. Saifee, Jennifer Andrews, Mary Berg, Stella T. Chou, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Juliana A. Guarente, Tina Ipe, Jeremy W. Jacobs, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Thane A. Kubik, Theodros Mamo, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Scott E. Potter, Simon J. Stanworth, Moritz Stolla, Alyssa Ziman, Ryan A. Metcalf   +24 more
wiley   +1 more source

Early occurrence of red blood cell alloimmunization in patients with sickle cell disease

, 2016
Red blood cell (RBC) alloimmunization is a major complication of transfusion therapy in sickle cell disease (SCD). Identification of high-risk patients is hampered by lack of studies that take the cumulative transfusion exposure into account.
von Ronnen, F. B., Cnossen, Marjon H., de Haas, Masja, Sins, Joep W. R., Rijneveld, Anita W., van der Bom, Johanna G., Kerkhoffs, Jean-Louis H., Fijnvandraat, Karin, van den Bersselaar, Sil M., Heijboer, H., Zalpuri, Saurabh, de Rijke, Yolanda B., Ellen van der Schoot, C., Biemond, Bart J., van Meurs, Alfred H.   +14 more
core   +1 more source

Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease

, 2017
Key PointsVariation in the Fcγ receptor gene cluster is associated with protection from RBC alloimmunization in patients with SCD. This association appears to be strongest for alloimmunization to antigens other than the immunogenic Rh or K.
Joep W. R. Sins, France Pirenne, Sadaf Pakdaman, Judy Geissler, Michael W. Tanck, Bart J. Biemond, Sanne M. Meinderts, Taco W. Kuijpers, Robin van Bruggen, Anita W. Rijneveld, Sietse Q. Nagelkerke, Timo K. van den Berg, Karin Fijnvandraat, Anoosha Habibi, Christine Bruggeman, Jean-Louis H. Kerkhoffs   +15 more
core   +1 more source

Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India

Advances in Hematology, 2015
Introduction. Red blood cell (RBC) alloimmunization and autoimmunization remain a major problem in transfusion dependent thalassemic patients. There is a paucity of data on the incidence of RBC alloimmunization and autoimmunization in thalassemic ...
Suvro Sankha Datta, Somnath Mukherjee, Biplabendu Talukder, Prasun Bhattacharya, Krishnendu Mukherjee   +4 more
doaj   +1 more source

Red blood cell alloimmunization in sickle cell disease patients in Tanzania

, 2014
Objective: Alloimmunization is a recognized complication of red blood cell (RBC) transfusion and causes delayed hemolytic transfusion reactions and provides problems sourcing compatible blood for future transfusions.
Marlow, T, Makani, J, Meda, E, Magesa, PM, Reid, C, Roberts, DJ   +5 more
core   +1 more source

Red blood cell alloimmunization among recipients of blood transfusion in India: A systematic review and meta‐analysis

Vox Sanguinis, 2022
S. Shastry, Deepika Chenna, A. Basavarajegowda, Soumya Das, R. Chaudhary   +4 more
semanticscholar   +1 more source